StonvexLoading…
StonvexStonvexStonvexCore line items from MCK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Annual 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $105.22B | $403.43B | $307.13B | $200.98B | $97.83B |
Operating Income | Not available | $6.21B | $4.06B | $2.44B | $1.04B |
Net Income | Not available | $4.76B | $3.08B | $1.89B | $784.00M |
EPS (Diluted) | $9.66 | $38.38 | $24.73 | $15.16 | $6.25 |
Total Assets | Not available | $82.32B | $84.19B | $84.16B | $81.31B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $3.98B | $2.96B | $4.00B | $2.42B |
Free Cash Flow OCF − CapEx | Not available | $5.72B | $2.41B | $1.28B | $-1.03B |
Shares Outstanding | Not available | 124.10M | 124.50M | 124.90M | 125.50M |